1.
Ang WH. Development of Organometallic Ruthenium(II) Anticancer (RAPTA) Drugs. Chimia [Internet]. 2007 Apr. 25 [cited 2024 Nov. 27];61(4):140. Available from: https://www.chimia.ch/chimia/article/view/2007_140